Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Well Lead Medical CoSHSE:603309 +0.17%84 FCF Margin % is 18.56% as of Jun. 2026, which is 276% above its 10-year median of 4.93. GuruFocus rates SHSE:603309 with a GF Score™ of 84/100 and a GF Value™ of ¥14.48 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Well Lead Medical Co ranks better than 85.14% on this metric.
The historical rank and industry rank for Well Lead Medical Co's FCF Margin % or its related term are showing as below:
SHSE:603309'
s FCF Margin % Range Over the Past 10 Years
Min: -9.76 Med: 4.93 Max: 15.38
Current: 14.89
During the past 13 years, the highest FCF Margin % of Well Lead Medical Co was 15.38%. The lowest was -9.76%. And the median was 4.93%.
SHSE:603309's FCF Margin % is ranked better than 85.14% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: -0.72
vs SHSE:603309: 14.89
The historical data trend for Well Lead Medical Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603309 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Well Lead Medical Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Well Lead Medical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Well Lead Medical Co (SHSE:603309) has a FCF Margin % of 18.56% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Well Lead Medical Co and its competitors. This is 276% above median its historical median of 4.93. According to the industry distribution chart, Well Lead Medical Co ranks #121 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 14.9%.
Is Well Lead Medical Co's FCF Margin % too high?
Well Lead Medical Co's current FCF Margin % of 18.56% is 276% above median its 10-year median of 4.93. Based on the distribution chart, Well Lead Medical Co ranks #121 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Well Lead Medical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Well Lead Medical Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Well Lead Medical Co ranks #121 out of 814 companies for FCF Margin %. This places Well Lead Medical Co in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Well Lead Medical Co and its competitors. Well Lead Medical Co's current FCF Margin % is 18.56%, which is 276% above median its own 10-year median of 4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Well Lead Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Well Lead Medical Co (SHSE:603309) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.48, compared to a current price of ¥11.59 — trading 20% below its estimated fair value. The current FCF Margin % is 18.56%, which is 276% above median its 10-year median of 4.93. Well Lead Medical Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Well Lead Medical Co (SHSE:603309), the current FCF Margin % is 18.56% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?
Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued.
The current stock price of ¥11.59 is trading 20% below its estimated GF Value™ of ¥14.48.
GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603309:
FCF Margin %: 18.56% (276% above median its 10-year median of 4.93)
GF Value™: ¥14.48 vs. price of ¥11.59 (20% below fair value)
No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
84GF Score
Get the complete analysis for SHSE:603309
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603309 has been successfully added to your 
